DUBLIN–(BUSINESS WIRE)–The “Collaboration Deals in Pharmaceuticals 2020-2025” report has been added to ResearchAndMarkets.com’s offering.
Collaboration Deals in Pharmaceuticals provides a detailed understanding and analysis of how and why companies enter collaboration deals. Fully revised and updated, the report provides details of collaboration deals from 2020 to 2025.
The report provides the reader with the following key benefits:
- Understand deal trends since 2020
- Browse collaboration deals
- Benchmark analysis – identify market value of transactions
- Financials terms – upfront, milestone, royalties
- Directory of deals by company A-Z, therapy focus and technology type
- Leading deals by value
- Most active dealmakers
- Identify assets and deal terms for each transaction
- Access contract documents – insights into deal structures
- Due diligence – assess suitability of your proposed deal terms for partner companies
- Save hundreds of hours of research time
Report Scope
Collaboration Deals in Pharmaceuticals is intended to provide the reader with an in-depth understanding of the collaboration trends and structure of deals entered into by leading biopharma companies worldwide.
The report includes:
- Trends in collaboration dealmaking in the biopharma industry
- Overview of collaboration deal structure
- Directory of collaboration deal records covering pharmaceutical and biotechnology
- The leading collaboration deals by value
- Most active collaboration dealmakers
- The leading collaboration partnering resources
Available deals are listed by:
- Company A-Z
- Headline value
- Therapeutic area
- Technology type
Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
Collaboration Deals in Pharmaceuticals provides comprehensive access to available records for collaboration deals, including contract documents where available.
Analyzing contract agreements allows due diligence of:
- What are the rights granted or optioned?
- What rights are granted by the agreement?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How are sales and payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are intellectual property rights handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and manufacture?
- How is confidentiality and publication managed?
- How are disputes resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What subcollaboration and subcontracting provisions have been agreed?
- Which boilerplate clauses does the company insist upon?
- Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
- Which jurisdiction does the company insist upon for agreement law?
Some of the companies featured in the report include:
- 3D Medicines
- 3T Biosciences
- 4B Technologies
- 4C Biomed
- 4D Pharma
- 4P-Pharma
- 7 Hills Pharma
- 9 Meters Biopharma
- 23andMe
- 48Hour Discovery
- 111
- A*STAR Singapore Immunology Network
- A2 Biotherapeutics
- Aachen University
- Abbisko Therapeutics
- Abbott Laboratories
- Abbvie
- AbCellera Biologics
- Abdul Latif Jameel Health
- Abilita Therapeutics
- ABL Bio
- AbSci
- AbTherx
- ACADIA Pharmaceuticals
- AC Bioscience
- Accent Therapeutics
- Accenture
- Access to Comprehensive Genomic Profiling Coalition
- ACEA Therapeutics
- Acepodia
- Acerand Therapeutics
- Acerta Pharma
- Acer Therapeutics
- Ache
- Actelion
- Actinium Pharmaceuticals
- Actuate Therapeutics
- Acumen Analytics
- Acumen Pharmaceuticals
- Adagene
- Adapsyn Bioscience
- Adaptimmune
- Adaptive Biotechnologies
- Adaptive Phage Therapeutics
- Addex Therapeutics
- Adimab
- ADMA Biologics
- Adrestia
- Advancell
- Aelis Pharma
- Aequus Pharmaceuticals
- Aerami Therapeutics
- Aerie Pharmaceuticals
- AESOP Technology
- Aethon Therapeutics
- and many, many more!
For more information about this report visit https://www.researchandmarkets.com/r/2uu3pt
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900